Flagship Biosciences is a pathologist-owned pathology CRO that bridges the gap between medical device firms and large contract research organizations. By using novel whole slide imaging and tissue analysis technology, Flagship makes tissue measurements of efficacy and toxicity more accurately and quickly than the industry accepted visual scores by pathologists. They provide tissue procurement, immunohistochemistry services, and expert pathology evaluation in diabetes, oncology, and other disease areas.